Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States
Retrieved on:
Tuesday, June 22, 2021
Managed care, Pharmaceutical, Health, Drugs, Chemical compounds, Health, Formamides, Formoterol, Phenols, Combination drugs, Chronic obstructive pulmonary disease, Beclometasone/formoterol/glycopyrronium bromide, Budesonide/formoterol, Formoterol Fumarate Inhalation Solution,, Teva, FORMOTEROL FUMARATE INHALATION SOLUTION,, TEVA
It is not known if the medicine formoterol in formoterol fumarate inhalation solution passes into breast milk and if it can harm your baby.
Key Points:
- It is not known if the medicine formoterol in formoterol fumarate inhalation solution passes into breast milk and if it can harm your baby.
- It is not known if the medicine formoterol in formoterol fumarate inhalation solution passes into breast milk and if it can harm your baby.
- Formoterol fumarate inhalation solution and certain other medicines may interact with each other.
- If your COPD symptoms worsen over time, do not increase your dose of formoterol fumarate inhalation solution, instead call your healthcare provider.